scholarly journals Stereotactic laser interstitial thermal therapy corpus callosotomy for the treatment of pediatric drug‐resistant epilepsy

2021 ◽  
Author(s):  
Arka N. Mallela ◽  
Jasmine L. Hect ◽  
Hussam Abou‐Al‐Shaar ◽  
Emefa Akwayena ◽  
Taylor J. Abel
Keyword(s):  
Thermal Therapy ◽  
Drug Resistant ◽  
Corpus Callosotomy ◽  
Pediatric Drug ◽  
Laser Interstitial Thermal Therapy ◽  
Drug Resistant Epilepsy

Laser interstitial thermal therapy in drug-resistant epilepsy

2019 ◽  
Vol 32 (2) ◽  
pp. 237-245 ◽  
Author(s):  
Shoichi Shimamoto ◽  
Chengyuan Wu ◽  
Michael R. Sperling
Keyword(s):  
Thermal Therapy ◽  
Drug Resistant ◽  
Laser Interstitial Thermal Therapy ◽  
Drug Resistant Epilepsy

MR-guided laser interstitial thermal therapy for pediatric drug-resistant lesional epilepsy

Epilepsia ◽  
2015 ◽  
Vol 56 (10) ◽  
pp. 1590-1598 ◽  
Author(s):  
Evan Cole Lewis ◽  
Alexander G. Weil ◽  
Michael Duchowny ◽  
Sanjiv Bhatia ◽  
John Ragheb ◽  
...  
Keyword(s):  
Thermal Therapy ◽  
Drug Resistant ◽  
Pediatric Drug ◽  
Laser Interstitial Thermal Therapy

JOURNAL CLUB: Longitudinal Qualitative Characterization of MRI Features After Laser Interstitial Thermal Therapy in Drug-Resistant Epilepsy

2017 ◽  
Vol 208 (1) ◽  
pp. 48-56 ◽  
Author(s):  
Kofi-Buaku Atsina ◽  
Ashwini D. Sharan ◽  
Chengyuan Wu ◽  
James J. Evans ◽  
Michael R. Sperling ◽  
...  
Keyword(s):  
Journal Club ◽  
Thermal Therapy ◽  
Drug Resistant ◽  
Laser Interstitial Thermal Therapy ◽  
Mri Features ◽  
Drug Resistant Epilepsy

The role of targeted gene panel in pediatric drug-resistant epilepsy

2020 ◽  
Vol 106 ◽  
pp. 107003
Author(s):  
Chang-Chun Wu ◽  
Meng-Han Tsai ◽  
Yen-Ju Chu ◽  
Wen-Chin Weng ◽  
Pi-Chuan Fan ◽  
...  
Keyword(s):  
Gene Panel ◽  
Drug Resistant ◽  
Pediatric Drug ◽  
Drug Resistant Epilepsy

scholarly journals Novel Neurotechnological Interventions for Pediatric Drug-Resistant Epilepsy: Physician Perspectives

2020 ◽  
pp. 088307382096693
Author(s):  
Patrick J. McDonald ◽  
Viorica Hrincu ◽  
Mary B. Connolly ◽  
Mark J. Harrison ◽  
George M. Ibrahim ◽  
...  
Keyword(s):  
Decision Making ◽  
Best Practice ◽  
Clinical Decision Making ◽  
Qualitative Content Analysis ◽  
Scientific Evidence ◽  
Clinical Decision ◽  
Drug Resistant ◽  
Ethical Considerations ◽  
Pediatric Drug ◽  
Drug Resistant Epilepsy

This qualitative study investigated factors that guide physicians’ choices for minimally invasive and neuromodulatory interventions as alternatives to conventional surgery or medical management for pediatric drug-resistant epilepsy. North American physicians were recruited to one of 4 focus groups at national conferences. Discussions were analyzed using qualitative content analysis. A pragmatic neuroethics framework was applied to interpret results. Discussions revealed 2 major thematic branches: (1) clinical decision making and (2) ethical considerations. Under clinical decision making, physicians emphasized scientific evidence and patient candidacy when assessing neurotechnologies for patients. Ongoing seizures without intervention was important for safety and neurodevelopment. Under ethical considerations, resource allocation, among other financial considerations for technology adoption, were considerable sources of pressure on decision making. Access to neurotechnology was a salient theme differentiating Canadian and American contexts. When assessing novel neurotechnological interventions for pediatric drug-resistant epilepsy, physicians balance clinical and ethical factors to guide decision making and best practice.

Sign in / Sign up

Export Citation Format

Share Document